Sequenom Inks Agreement with Coventry for Coverage of T21 Test | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom today said that health insurance provider Coventry Health Care National Network will provide coverage for its T21 test.

According to Sequenom, the 2.2 million members of Coventry's First Health PPO network will have coverage for its MaterniT21 Plus testing service. The test, which detects for the presence of trisomy 21, 18, and 13, is performed at the firm's lab, the Sequenom Center for Molecular Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.